The AvecNet Trial to assess whether addition of pyriproxyfen, an insect juvenile hormone mimic, to long-lasting insecticidal mosquito nets provides additional protection against clinical malaria over current best practice in an area with pyrethroid-resistant vectors in rural Burkina Faso: Study protocol for a randomised controlled trial

Trials

Volumn 16, Issue 1, 2015, Pages

  Tiono, Alfred B ^a   Pinder, Margaret ^b,c   N'Fale, Sagnon ^a   Faragher, Brian ^d   Smith, Tom ^e   Silkey, Mariabeth ^e   Ranson, Hilary ^d   Lindsay, Steve W ^b  

^a Burkina Faso   (Burkina Faso)

^b DURHAM UNIVERSITY   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Clinical malaria; Cluster randomized controlled trial; Entomological inoculation rate; Insect juvenile hormone mimic; Insecticide resistance management; Insecticide treated bed net; Malaria control; Pyrethroid; Pyriproxyfen

Indexed keywords

PERMETHRIN; PYRIPROXYFEN; INSECTICIDE; PYRIDINE DERIVATIVE;

ANEMIA; ARTICLE; BED NET; BURKINA FASO; CHILD; CLINICAL PRACTICE; CLINICAL PROTOCOL; CONTROLLED STUDY; HUMAN; INCIDENCE; INFANT; INFECTION RATE; INSECTICIDE RESISTANCE; MALARIA; MALARIA CONTROL; NONHUMAN; PARASITE PREVALENCE; PLASMODIUM; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIAL; SPOROZOITE; VECTOR CONTROL; AGE; ANIMAL; ANOPHELES; DISEASE CARRIER; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; INSECTICIDE TREATED NET; METHODOLOGY; MOSQUITO CONTROL; PARASITOLOGY; PRESCHOOL CHILD; PROCEDURES; TIME FACTOR; TRANSMISSION;

AGE FACTORS; ANIMALS; ANOPHELES; BURKINA FASO; CHILD, PRESCHOOL; DISEASE VECTORS; HUMANS; INCIDENCE; INFANT; INSECTICIDE RESISTANCE; INSECTICIDE-TREATED BEDNETS; INSECTICIDES; MALARIA; MOSQUITO CONTROL; PLASMODIUM; PYRIDINES; RESEARCH DESIGN; TIME FACTORS;

EID: 84925605853     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0606-4     Document Type: Article

References (46)

1. O'Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10:545-55.
2. WHO. World Malaria Report 2014. Geneva: WHO; 2014.
3. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;2, CD000363.
4. Pluess B, Tanser FC, Lengeler C, Sharp BL. Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev. 2010;4, CD006657.
5. Ranson H, N'Guessan R, Lines J, Moiroux N, Nkuni Z, Corbel V. Pyrethroid resistance in African anopheline mosquitoes: what are the implications for malaria control? Trends Parasitol. 2011;27:91-8.
6. WHO. Pesticides and Their Application for the Control of Vectors and Pest of Public Health Importance. 6th ed. Geneva: WHO; 2006.
7. Zaim M, Aitio A, Nakashima N. Safety of pyrethroid-treated mosquito nets. Med Vet Entomol. 2000;14:1-5.
8. Snow RW, Rowan KM, Lindsay SW, Greenwood BM. A trial of bed nets (mosquito nets) as a malaria control strategy in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg. 1988;82:212-5.
9. Clarke SE, Bøgh C, Brown RC, Pinder M, Walraven GEL, Lindsay SW. Do untreated bednets protect against malaria? Trans R Soc Trop Med Hyg. 2001;95:457-62.
10. Ohashi K, Nakada K, Ishiwatari T, Miyaguchi J, Shono Y, Lucas JR, et al. Efficacy of pyriproxyfen-treated nets in sterilizing and shortening the longevity of Anopheles gambiae (Diptera: Culicidae). J Med Entomol. 2012;49:1052-8.
11. Ngufor C, N'Guessan R, Fagbohoun J, Odjo A, Malone D, Akogbeto M, et al. Olyset Duo (R) (a pyriproxyfen and permethrin mixture net): an experimental hut trial against pyrethroid resistant Anopheles gambiae and Culex quinquefasciatus in southern Benin. PLoS One. 2014;9:e83897.
12. Mbare M, Lindsay SW, Fillinger U. Pyriproxifen for mosquito control: female sterilization or horizontal transfer to oviposition substrates by Anopheles gambiae sensu stricto and Culex quinquefasciatus. Parasit Vectors. 2014;7:280.
13. Itoh T. Utilization of bloodfed females of Aedes aegypti as a vehicle for the transfer of the insect growth regulator, pyriproxyfen, to larval habitats. Tropic Med. 1994;36:243-8.
14. Hatakoshi M, Kawada H, Nishida S, Kisida H, Nakayama I. Laboratory evaluation of 2 -(1-methyl-2-(4-phenoxyphenoxy) ethoxy) pyridine against larvae of mosquitoes and housefly. Jpn J Sanit Zool. 1987;38:271-4.
15. Harris C, Lwetoijera DW, Dongus S, Matowo NS, Lorenz LM, Devine GJ, et al. Sterilising effects of pyriproxyfen on Anopheles arabiensis and its potential use in malaria control. Parasit Vectors. 2013;6:144.
16. Sihuincha M, Zamora-Perea E, Orellana-Rios W, Stanil JD, Lopez-Sifuentes V, Vidal-Ore C, et al. Potential use of pyriproxyfen for control of Aedes aegypti (Diptera: Culicidae) in Iquitos. Peru. J Med Entomol. 2005;42:620-30.
17. Yapabandara AM, Curtis CF. Laboratory and field comparisons of pyriproxyfen, polystyrene beads and other larvicidal methods against malaria vectors in Sri Lanka. Acta Trop. 2002;81:211-23.
18. Kouyate B, Sie A, Ye M, De Allegri M, Muller O. The great failure of malaria control in Africa: a district perspective from Burkina Faso. PLoS Med. 2007;4:e127.
19. Pinder M, Jawara M, Jarju LBS, Kandeh B, Jeffries D, Lluberas MF, et al. To assess whether indoor residual spraying can provide additional protection against clinical malaria over current best practice of long-lasting insecticidal mosquito nets in The Gambia: study protocol for a two-armed cluster-randomised trial. Trials. 2011;12:e147.
20. Dabiré K, Diabaté A, Namountougou M, Djogbenou L, Wondji C, Chandre F, et al. Trends in insecticide resistance in natural populations of malaria vectors in Burkina Faso, West Africa: 10 years' surveys. In: Perveen F, editor. Insecticides - Pest Engineering. 2012. On-line publication: Intech. http://www.intechopen.com/books/insecticides-pest-engineering/trends-in-insecticide-resistance-in-natural-populations-of-malaria-vectors-in-burkina-faso-west-afri .
21. Moorthy VS, Reed Z, Smith PG. Measurement of malaria vaccine efficacy in Phase III trials, report of a WHO consultation. Vaccine. 2007;25:5115-23.
22. Trape JF, Rogier C. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today. 1996;12:236-40.
23. Alonso PL, Lindsay SW, Armstrong Schellenberg JRM, Gomez P, Hill AG, David PH, et al. A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, West Africa. 2. Mortality and morbidity from malaria in the study area. Trans R Soc Trop Med Hyg. 1993;87:13-8.
24. Konate AT, Yaro JB, Ouedraogo AZ, Diarra A, Gansane A, Soulama I, et al. Morbidity from malaria in children in the year after they had received intermittent preventive treatment of malaria: a randomised trial. PLoS One. 2011;6.
25. Baudon DGP, Rea D, Carnevale P. A study of malaria morbidity in a rural area of Burkina Faso (West Africa). Trans R Soc Trop Med Hyg. 1985;79:283-4.
26. Smith T, Schellenberg JA, Hayes R. Attributable fraction estimates and case definitions for malaria in endemic areas. Stat Med. 1994;13:2345-58.
27. Lindsay SW, Shenton FC, Snow RW, Greenwood BM. Responses of Anopheles gambiae complex mosquitoes to the use of untreated bednets in The Gambia. Med Vet Entomol. 1989;3:253-62.
28. Wirtz RA, Duncan JF, Njelesani EK, Schneider I, Brown AE, Oster CN, et al. ELISA method for detecting Plasmodium falciparum circumsporozoite antibody. Bull World Health Organ. 1989;67:535-42.
29. Scott JA, Brogdon WG, Collins FH. Identification of single specimens of the Anopheles gambiae complex by the polymerase chain reaction. Am J Trop Med Hyg. 1993;49:520-9.
30. Fanello C, Santolamazza F, della Torre A. Simultaneous identification of species and molecular forms of the Anopheles gambiae complex by PCR-RFLP. Med Vet Entomol. 2002;16:461-4.
31. Bass C, Nikou D, Donnelly MJ, Williamson MS, Ranson H, Ball A, et al. Detection of knockdown resistance kdr mutations in Anopheles gambiae: a comparison of two new high-throughput assays with existing methods. Malar J. 2007;6:e111.
32. Jones CM, Liyanapathirana M, Agossa FR, Weetman D, Ranson H, Donnelly MJ, et al. Footprints of positive selection associated with a mutation (N1575Y) in the voltage-gated sodium channel of Anopheles gambiae. Proc Natl Acad Sci U S A. 2012;109:6614-9.
33. WHO. Test Procedures for Insecticide Resistance Monitoring in Malaria Vector Mosquitoes. Geneva: WHO; 2013.
34. Smith PG, Morrow R. Field Trials of Health Interventions in Developing Countries: A Toolbox. London: Macmillan; 1996.
35. Hayes RJ, Bennett S. Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999;28:319-26.
36. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 2006;35:1292-300.
37. Kleinschmidt I, Omumbo J, Briet O, van de Giesen N, Sogoba N, Mensah NK, et al. An empirical malaria distribution map for West Africa. Trop Med Int Health. 2001;6:779-86.
38. Hawley WA, Phillips-Howard PA, ter Kuile FO, Terlouw DJ, Vulule JM, Ombok M, et al. Community-wide effects of permethrin-treated bed nets on child mortality and malaria morbidity in western Kenya. Am J Trop Med Hyg. 2003;68:121-7.
39. Schellenberg D, Aponte J, Kahigwa E, Mshinda H, Tanner M, Menendez C, et al. The incidence of clinical malaria detected by active case detection in children in Ifakara, southern Tanzania. Trans R Soc Trop Med Hyg. 2003;97:647-54.
40. Brabin B. An analysis of malaria parasite rates in infants: 40 years after MacDonald. Trop Dis Bull. 1990;87:20.
41. Bruce-Chwatt LJ. Malaria in African infants and children in Southern Nigeria. Ann Trop Med Parasitol. 1952;46:173-200.
42. Macdonald G. The analysis of malaria parasite rates in infants. Trop Dis Bull. 1950;47:915-38.
43. Snow RW, Nahlen B, Palmer A, Donnelly CA, Gupta S, Marsh K. Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. J Infect Dis. 1998;177:819-22.
44. Cohen S, Mc GI, Carrington S. Gamma-globulin and acquired immunity to human malaria. Nature. 1961;192:733-7.
45. Edozien JC, Gilles HM, Udeozo IOK. Adult and cord-blood gamma-globulin and immunity to malaria in Nigerians. Lancet. 1962;280:951-5.
46. McGregor IA, Carrington SP, Cohen S. Treatment of East African P. falciparum malaria with West African human γ-globulin. Trans R Soc Trop Med Hyg. 1963;57:170-5.